Figures and numbers updated: 6/02/2021

Total Number of Active Participants: 68,219 (Active is defined as the participants that have enrolled and not withdrawn consent)

Our goal is to enroll a representative sample of participants in the COVID-19 Community Partnership Research study over the next few months, with particular interest in the elderly (age 65 and older) and racial/ethnic minority groups. The data below reflects study participation since April 2020.

Total Completed Daily Symptom Logs: 8,255,918

The COVID-19 Community Research Partnership Celebrates its One-year Anniversary.

On April 9, 2020, we officially enrolled our first participants. And thanks to all of you, we have learned so much about how to fight COVID-19. Since then...

• We have enrolled over 59,007 study participants nationally.
• We have results for over 93,990 antibody tests.
• Study participants have completed over 6,496,983 total daily surveys. Below are some of the participants who have completed the most daily surveys:
• Michael F.
• Melanie H.
• John P.
• Arjun C.
• Marijo C.
• Jennifer D.
• Because of you, we have provided valuable data to the Centers for Disease Control about the prevalence of the COVID-19 antibody as well as the effectiveness of the vaccine.

The graphic below shows how many symptoms and the type of symptoms you reported since the beginning of the study. This data helped us to predict how the virus moved through our community.

Total symptoms

Fever: 12,303	Shortness of Breath: 47,474
Sore Throat: 101,876	Blue Lips: 281
Cough: 163,676	Muscle Pain: 157,224
Congestion: 219,329	Anosmia(Loss of Taste/Smell): 11,740
Confused: 2,742	Nausea: 32,852
Fatigue: 49,477	Chest Pain: 9,425
Headache: 185,632	Chills: 6,096
Diarrhea: 49,370

Total Study Participants by Age:

Race/Ethnicity Breakdown of Participants:

We recognize that people of color continue to be underrepresented in research, including this study. To address this concern, we have partnered with several community-based organizations to increase access to the study and raise awareness about COVID-19. We will continue to work to increase representation from African American and Latinx community members to ensure we have adequate data to better understand how COVID-19 is affecting members of those communities.

Total Study Participants by Race/Ethnicity:

There are 68,219 participants currently enrolled in this study. Approximately 85% of participants are White. People of color make up 15% of the total study participants. This bar graph breaks down the demographics of the portion of participants that have activated their account and given at least one symptomatic status update (n= 58,641).

Breakdown of Participants by Sex:

Cumulative Antibody Testing Participants:

There are 46,097 participants currently enrolled in the antibody testing portion of the study. This graph reflects the change in the total number of participants enrolled in the antibody testing portion of the study over time. Below are variations on this graphic that breakdown the antibody testing participants by gender and ethnicity over time.

Cumulative Antibody Testing Participants Broken Down by Gender:

Cumulative Antibody Testing Participants Broken Down by Race/Ethnicity: